Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Capital Expenditures (2017)

Historic Capital Expenditures for vTv Therapeutics (VTVT) over the last 3 years, with Q4 2017 value amounting to $18000.0.

  • vTv Therapeutics' Capital Expenditures changed N/A to $18000.0 in Q4 2017 from the same period last year, while for Dec 2021 it was $18000.0, marking a year-over-year change of. This contributed to the annual value of $21000.0 for FY2022, which is N/A changed from last year.
  • Per vTv Therapeutics' latest filing, its Capital Expenditures stood at $18000.0 for Q4 2017.
  • In the past 5 years, vTv Therapeutics' Capital Expenditures registered a high of $62000.0 during Q4 2015, and its lowest value of -$2000.0 during Q4 2014.
  • Over the past 3 years, vTv Therapeutics' median Capital Expenditures value was $13500.0 (recorded in 2014), while the average stood at $21000.0.
  • The largest annual percentage gain for vTv Therapeutics' Capital Expenditures in the last 5 years was 320000.0% (2015), contrasted with its biggest fall of 0.0% (2015).
  • Over the past 3 years, vTv Therapeutics' Capital Expenditures (Quarter) stood at -$2000.0 in 2014, then surged by 3200.0% to $62000.0 in 2015, then plummeted by 70.97% to $18000.0 in 2017.
  • Its last three reported values are $18000.0 in Q4 2017, $39000.0 for Q1 2017, and $62000.0 during Q4 2015.